Fernando Bril, M.D.A research manuscript by Fernando Bril, M.D., assistant professor in the UAB Department of Medicine Division of Endocrinology, Diabetes, and Metabolism, is featured in the Endocrine Society’s Article Highlights of 2025, a selective list celebrating the quality and excellence of articles published in the past year.
The compilation includes 25 articles from Endocrinology, The Journal of Clinical Endocrinology & Metabolism, Journal of the Endocrine Society, Endocrine Reviews, and JCEM Case Reports. The Endocrine Society selected five articles from each journal for their excellence, as assessed by citations, downloads, and recognition from the editors.
Bril is an associate scientist in the UAB Comprehensive Diabetes Center and has published more than 90 publications in the field of metabolic dysfunction-associated steatohepatitis (MASLD), Type 2 diabetes, and obesity.
Bril’s featured article, “Prevalence of MASLD in People With Diabetes Has Decreased in the US, but Rates of Liver Fibrosis Are Still on the Rise,” appeared in the Journal of the Endocrine Society, Volume 9, Issue 8, August 2025.
His study provides the first evidence MASLD prevalence is beginning to decrease in adults with diabetes in the U.S. for the first time in decades. However, the prevalence of clinically significant fibrosis, advanced fibrosis, and cirrhosis has significantly increased, especially among individuals with diabetes. Read more about his findings here.